ArticleCase reports in endocrinology2021

Pembrolizumab in a Patient with Treatment-Naïve Unresectable BRAF-Mutation Negative Anaplastic Thyroid Cancer.

Fadi Nabhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.